Search results for "10054 Clinic for Psychiatry"

showing 10 items of 12 documents

Meta-analysis of real-time fMRI neurofeedback studies using individual participant data: How is brain regulation mediated?

2015

An increasing number of studies using real-time fMRI neurofeedback have demonstrated that successful regulation of neural activity is possible in various brain regions. Since these studies focused on the regulated region(s), little is known about the target-independent mechanisms associated with neurofeedback-guided control of brain activation, i.e. the regulating network. While the specificity of the activation during self-regulation is an important factor, no study has effectively determined the network involved in self-regulation in general. In an effort to detect regions that are responsible for the act of brain regulation, we performed a post-hoc analysis of data involving different ta…

2805 Cognitive NeuroscienceVentrolateral prefrontal cortexBrain regulationCognitive NeuroscienceStress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]610 Medicine & healthCIBM-SPCddc:616.0757Brain mapping050105 experimental psychologyProcedural memory03 medical and health sciences0302 clinical medicineBasal gangliamedicineHumans0501 psychology and cognitive sciencesAnterior cingulate cortexBrain Mapping05 social sciencesBrainCognitionNeurofeedbackMagnetic Resonance Imagingmedicine.anatomical_structureNeurofeedback Real-time fMRI Brain regulationNeurology10054 Clinic for Psychiatry Psychotherapy and Psychosomatics2808 NeurologyMeta-analysisReal-time fMRINeurofeedbackPsychologyNeuroscience030217 neurology & neurosurgeryBrain Regulation ; Neurofeedback ; Real-time FmriNeuroImage
researchProduct

Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-cont…

2013

Background The catechol-O-methyltransferase (COMT) modulates dopaminergic neurotransmission in the prefrontal cortex as well as in the mesolimbic reward system. Since the reward system mediates addictive behavior, the COMT gene is a strong candidate gene regarding the pathophysiology of tobacco dependence and smoking behavior. Because of rather conflicting results in previous studies, the purpose of the present study was to test for association between a functional genetic variant in the COMT gene (single nucleotide polymorphism [SNP] rs4680) and tobacco smoking behavior. Methods In a population-based case-control multicenter study designed for tobacco addiction research, a total of 551 cur…

AdultCandidate genemedia_common.quotation_subjectPopulationEuropean Continental Ancestry Groupgenetics [Catechol O-Methyltransferase]Single-nucleotide polymorphism610 Medicine & healthCatechol O-MethyltransferasePolymorphism Single NucleotideWhite PeopleGermanymental disordersSNPMedicineHumanseducationmedia_commonGeneticseducation.field_of_studyCatechol-O-methyl transferasebusiness.industryAddictionSmokingPublic Health Environmental and Occupational Healthgenetics [Smoking]Tobacco Use Disorder2739 Public Health Environmental and Occupational HealthMiddle Agedmedicine.diseaseCase-Control Studies10054 Clinic for Psychiatry Psychotherapy and Psychosomaticsddc:640genetics [Tobacco Use Disorder]businessAddictive behaviorrs4680
researchProduct

Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women

2013

<b><i>Objective:</i></b> The neuropeptide-Y (NP-Y) gene is a strong candidate gene in the pathophysiology of obesity-linked behavior, and several single-nucleotide polymorphisms of NP-Y have already been linked to body weight and appetite. However, the results from current studies remain inconclusive. The aim of the present study was to test whether a certain functional genetic variant (SNP rs16147) in the NP-Y promoter gene is associated with serum leptin levels and body fat distribution. <b><i>Method:</i></b> We genotyped and measured the serum leptin levels of the NP-Y rs16147 polymorphism in 1,097 Caucasian subjects in the context of a pop…

AdultMaleLeptinCandidate genemedicine.medical_specialtyGenotypeblood [Leptin]Medicine (miscellaneous)610 Medicine & healthmacromolecular substancesPolymorphism Single NucleotideWhite PeopleStatistics NonparametricWaist–hip ratiogenetics [Obesity]Sex FactorsMedizinische FakultätInternal medicineGenotypemedicineHumansNeuropeptide YObesityddc:610Genephysiology [Neuropeptide Y]Nutrition and Dieteticsbusiness.industryWaist-Hip RatioLeptinCase-control study2701 Medicine (miscellaneous)Middle AgedNeuropeptide Y receptormedicine.diseaseObesitygenetics [European Continental Ancestry Group]EndocrinologyCase-Control Studies10054 Clinic for Psychiatry Psychotherapy and Psychosomatics2916 Nutrition and DieteticsFemalegenetics [Neuropeptide Y]businessphysiology [Polymorphism Single Nucleotide]
researchProduct

Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study

2020

Abstract Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study (COMPAS) was a prospective, randomized multicenter clinical trial, comparing methylphenidate (MPH) with placebo (PLAC) in combination with cognitive behavioral group psychotherapy (GPT) or individual clinical management (CM) over the period of 1 year. Here, we report results on treatment safety. Methods MPH and PLAC were flexibly dosed. Among 433 randomized patients, adverse events (AEs) were documented and analyzed on an “as received” basis during week 0–52. Electrocardiogram data were recorded at baseline and week 24. Results Comparing 205 patients who received ≥1 dose of MPH with 209 patients wh…

AdultMaleTachycardiamedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentMedizin610 Medicine & healthPlaceboGroup psychotherapyYoung Adult2738 Psychiatry and Mental Health03 medical and health sciences0302 clinical medicineDouble-Blind MethodInternal medicinemedicinePalpitationsHumans2736 Pharmacology (medical)Pharmacology (medical)Prospective StudiesAdverse effectCognitive Behavioral TherapyHyperhidrosisMethylphenidatebusiness.industryGeneral MedicineMiddle AgedCombined Modality Therapy3. Good health030227 psychiatryClinical trialPsychiatry and Mental healthAttention Deficit Disorder with Hyperactivity10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMethylphenidateCentral Nervous System StimulantsFemalePatient Safetymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugPharmacopsychiatry
researchProduct

Early detection of the risk of developing psychiatric disorders: a study of 461 Chinese university students under chronic stress

2019

Chronic stress, a characteristic of modern time, has a significant impact on general health. In the context of psychiatric disorders, insufficient coping behavior under chronic stress has been linked to higher rates of (1) depressive symptoms among subjects of the general population, (2) relapse among patients under treatment for clinical depression, and (3) negative symptoms among subjects with an elevated vulnerability to psychosis. In this normative study we assessed basic coping behavior among 461 Chinese freshman university students along with their consumption behavior and general health in terms of regular exercises, physical health, psychosomatic disturbances, and mental health. The…

AdultMalemedicine.medical_specialtyAdolescentUniversitiesPopulationEthnic groupNeural netsNormative dataContext (language use)610 Medicine & healthBasic coping behavior03 medical and health sciencesYoung Adult2738 Psychiatry and Mental Health0302 clinical medicineRisk FactorsmedicineHumanseducationPsychiatryStudentsSocioeconomic statusDepression (differential diagnoses)education.field_of_studyPrevention3203 Clinical PsychologyEarly detectionCollege/university studentsMental healthPsychophysiologic Disorders030227 psychiatryPsychotherapyPsychiatry and Mental healthClinical PsychologyEarly Diagnosis10072 Institute of Response Genetics10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsNormativeFemaleChronic stressMental healthPsychologyRisk assessmentPrediction030217 neurology & neurosurgeryStress PsychologicalResearch Article
researchProduct

Release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by ischemic preconditioning: No eviden…

2003

Abstract The release of choline as a water-soluble product of phospholipid hydrolysis was measured in the perfusate of rat hearts to monitor ischemic membrane degradation and its protection by ischemic preconditioning (IPC). Hearts were subjected to global ischemia (GI; 30 min of no-flow) followed by 60 min of reperfusion. To induce IPC, GI was preceded by four no-flow episodes of 5 min each. Deleterious consequences of GI and reperfusion, namely coronary flow reduction, incidence of arrhythmias and release of cardiac troponin T, were significantly attenuated by IPC. The release of choline increased during reperfusion in a biphasic manner: a first phase peaked immediately after GI and was f…

IschemiaPhospholipid610 Medicine & healthArachidonic AcidsPharmacologyPhospholipasePhospholipases AGeneral Biochemistry Genetics and Molecular Biology3000 General Pharmacology Toxicology and PharmaceuticsCholineRats Sprague-Dawleychemistry.chemical_compoundTroponin T1300 General Biochemistry Genetics and Molecular Biologyparasitic diseasesPhospholipase DmedicineAnimalsCholinecardiovascular diseasesGeneral Pharmacology Toxicology and PharmaceuticsPhospholipidsPhospholipase APhospholipase DMyocardiumGeneral Medicinemedicine.diseaseRatsPhospholipases A2CytosolchemistryBiochemistry10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsIschemic Preconditioning MyocardialIschemic preconditioninghuman activities
researchProduct

Standalone Smartphone Cognitive Behavioral Therapy–Based Ecological Momentary Interventions to Increase Mental Health: Narrative Review

2020

Background A growing number of psychological interventions are delivered via smartphones with the aim of increasing the efficacy and effectiveness of these treatments and providing scalable access to interventions for improving mental health. Most of the scientifically tested apps are based on cognitive behavioral therapy (CBT) principles, which are considered the gold standard for the treatment of most mental health problems. Objective This review investigates standalone smartphone-based ecological momentary interventions (EMIs) built on principles derived from CBT that aim to improve mental health. Methods We searched the MEDLINE, PsycINFO, EMBASE, and PubMed databases for peer-reviewed …

Male020205 medical informaticsEcological Momentary Assessmentmedicine.medical_treatmentPneumonia ViralMEDLINEPsychological interventionCBTHealth InformaticsContext (language use)Review02 engineering and technologyPsycINFOsmartphoneBetacoronavirus03 medical and health sciences0302 clinical medicinemobile appEconomic cost0202 electrical engineering electronic engineering information engineeringmedicineHumans030212 general & internal medicineEMIPandemicsmHealth2718 Health Informaticsmobile phoneCognitive Behavioral TherapySARS-CoV-210093 Institute of PsychologyEcologyMental DisordersCOVID-19Mobile ApplicationsMental healthTelemedicine3. Good healthCognitive behavioral therapyMental HealthmHealth10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsFemaleCoronavirus Infections150 PsychologyPsychologyecological momentary intervention10190 Jacobs Center for Productive Youth DevelopmentJMIR mHealth and uHealth
researchProduct

Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls

2013

Abstract Nicotine has been proposed to be a cognitive enhancer, particularly in schizophrenia patients. So far, the published studies of nicotine effects on antisaccade performance in schizophrenia patients only tested participants who were deprived smokers. Thus, we aimed to test both smoking and non-smoking patients as well as healthy controls in order to extend previous findings. Moreover, we employed a paradigm using standard and delayed trials. We hypothesized that, if nicotine is a genuine cognitive enhancer, its administration would improve antisaccade performance both in smoking and non-smoking participants. A total of 22 patients with schizophrenia (12 smokers and 10 non-smokers) a…

Malemedicine.medical_treatmentStatistics as TopicNicotine2738 Psychiatry and Mental Health0302 clinical medicine2736 Pharmacology (medical)Pharmacology (medical)Nicotinic AgonistsCotinineCross-Over StudiesSmokingCognitionMiddle Aged16. Peace & justice3. Good healthPsychiatry and Mental healthNicotinic acetylcholine receptor3004 PharmacologySchizophreniaFemaleSmoking statusPsychologymedicine.drugClinical psychologyAdultNicotinemedicine.medical_specialtyAdolescentNicotine patch610 Medicine & healthAdministration CutaneousYoung Adult03 medical and health sciencesDouble-Blind MethodInternal medicineReaction TimeSaccadesmedicineHumansEffects of sleep deprivation on cognitive performanceBeneficial effectsPharmacologyAnalysis of Variancemedicine.disease030227 psychiatryElectrooculography10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsSchizophrenia030217 neurology & neurosurgery
researchProduct

Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response i…

2008

André Tadic1, Dan Rujescu2, Matthias J Müller3, Ralf Kohnen4, Hans H. Stassen5, Armin Szegedi6, Norbert Dahmen11Department of Psychiatry, University of Mainz, Germany; 2Department of Psychiatry, University of Munich, Germany; 3Clinic for Psychiatry and Psychotherapy, Marburg-Sued, Germany, and Clinic for Psychiatry and Psychotherapy, Giessen, Germany; 4IMEREM, Nuernberg, Germany; 5Department of Psychiatry, University of Zurich, Switzerland; 6Organon, Roseland, NJ, USAAbstract: This study investigated the possible association of the interleukin-1 beta (IL-1β) C-511T promoter polymorphism and the interleukin-1 receptor antagonist (IL-1Ra) (86bp)n variable number o…

Neuropsychiatric Disease and Treatmentbusiness.industryMirtazapine610 Medicine & healthPharmacologyinterleukin-1 betaParoxetineantidepressive agentsPsychiatry and Mental healthVariable number tandem repeatInterleukin 1 receptor antagonistgenetic polymorphismsPolymorphism (computer science)10054 Clinic for Psychiatry Psychotherapy and Psychosomaticstreatment outcomeMedicineAntidepressantinterleukin-1 receptor antagonistmajor depressionbusinessBiological PsychiatryPharmacogeneticsOriginal ResearchGenetic associationmedicine.drug
researchProduct

Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis.

2022

Abstract Objective Neurological correlates of impaired insight in non-affective psychosis remain unclear. This study aimed to review and meta-analyze the studies assessing the grey matter volumetric correlates of impaired insight in non-affective psychosis. Methods This study consisted of a systematic review of 23 studies, and a meta-analysis with SDM-PSI of the 11 studies that were whole-brain and reported maps or peaks of correlation of studies investigating the grey matter volumetric correlates of insight assessments of non-affective psychosis, PubMed and OVID datasets were independently reviewed for articles reporting neuroimaging correlates of insight in non-affective psychosis. Qualit…

PsychosisPrecuneusBrainNeuroimaging610 Medicine & healthGeneral MedicineGrey mattermedicine.diseaseMagnetic Resonance ImagingCorrelationPsychiatry and Mental healthSuperior temporal gyrusmedicine.anatomical_structurePsychotic DisordersNeuroimaging10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMeta-analysismedicineHumansGeneral Earth and Planetary SciencesGray MatterPsychologyInsulaGeneral Environmental ScienceClinical psychologyRevista de psiquiatria y salud mental
researchProduct